Non-pharmacological approaches to migraine management
https://doi.org/10.21518/ms2025-530
Abstract
Migraine is a prevalent and socially significant neurological disorder that requires a comprehensive approach to both treatment and prevention. Non-pharmacological methods of migraine prevention are discussed. Particular attention is given to behavioral and lifestyle interventions such as trigger management, sleep and dietary hygiene, regular aerobic exercise, weight control, and cognitive-behavioral therapy (CBT). These approaches form the basis of non-pharmacological tactics in routine practice. In addition, methods targeting the neurobiological mechanisms of migraine are reviewed, including acupuncture, nutraceuticals (magnesium, riboflavin, coenzyme Q10, vitamin D, etc.), dietary interventions (ketogenic and DASH diets), and non-invasive neuromodulation (high-frequency transcranial magnetic stimulation, transcranial direct current stimulation, trigeminal and vagus nerve stimulation, and remote electrical neuromodulation). Non-pharmacological prevention significantly broadens the therapeutic arsenal for migraine. However, key challenges remain in the standardization of neuromodulation protocols, harmonization of outcome measures and follow-up durations, and validation of nutraceutical efficacy. In clinical practice, the most consistent preventive outcomes are achieved through an individualized approach emphasizing lifestyle modification, patient education, and CBT. A comprehensive approach is considered a promising strategy for managing patients with migraine. The synergistic effect of combining behavioral, physical, and instrumental techniques exceeds the results of their isolated use, making a comprehensive multimodal approach the most promising and reasonable tactic for achieving sustainable control over migraine, minimizing disability, and improving patients’ quality of life in the long term.
About the Authors
R. T. MurtazinaRussian Federation
Renata T. Murtazina, Research Intern, Department of Neurology, Institute of Clinical Medicine named after Sklifosovsky, Resident of the A.Ya. Kozhevnikov Clinic of Nervous Diseases
8, Bldg. 2, Trubetskaya St., Moscow, 119991
S. P. Bordovsky
Russian Federation
Sergey P. Bordovsky, Postgraduate Student of the Department of Nervous Diseases, Institute of Clinical Medicine named after Sklifosovsky
8, Bldg. 2, Trubetskaya St., Moscow, 119991
A. V. Varfolomeeva
Russian Federation
Arina V. Varfolomeeva, Student, Institute of Clinical Medicine named after Sklifosovsky
8, Bldg. 2, Trubetskaya St., Moscow, 119991
K. V. Shevtsova
Russian Federation
Kseniya V. Shevtsova, Cand. Sci. (Med.), Assistant, Department of Neurology, Institute of Clinical Medicine named after Sklifosovsky
8, Bldg. 2, Trubetskaya St., Moscow, 119991
References
1. Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):1–4. https://doi.org/10.1186/S10194-020-01208-0.
2. Haghdoost F, Togha M. Migraine management: Non-pharmacological points for patients and health care professionals. Open Med. 2022;17(1):1869. https://doi.org/10.1515/MED-2022-0598.
3. Casas-Limón J, Quintas S, López-Bravo A, Alpuente A, Andrés-López A, Castro-Sánchez MV et al. Unravelling Migraine Stigma: A Comprehensive Review of Its Impact and Strategies for Change. J Clin Med. 2024;13(17):5222. https://doi.org/10.3390/JCM13175222.
4. Diener H-C, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M et al. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia. 2020;40(10):1026–1044. https://doi.org/10.1177/0333102420941839.
5. Filatova EG, Osipova VV, Tabeeva GR, Parfenov VA, Ekusheva EV, Azimova YE et al. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-4-14.
6. Eller M, Cheng S. Migraine management: an update for the 2020s. Int Med J. 2022;52(7):1123. https://doi.org/10.1111/IMJ.15843.
7. Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis. Cephalalgia. 2017;37(5):470–485. https://doi.org/10.1177/0333102416678382.
8. Diener HC, Kropp P, Dresler T, Evers S, Förderreuther S, Gaul C et al. Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline. Neurol Res Pract. 2022;4(1):1–14. https://doi.org/10.1186/S42466-022-00200-0.
9. Tabeeva GR, Kosivtsova OV. Modern strategies for the treatment of migraine attacks and the possibility of a differentiated approach. Meditsinskiy Sovet. 2023;1(21):54–62. (In Russ.) https://doi.org/10.21518/ms2023-425.
10. Turankar T, Sorte A, Wanjari MB, Chakole S, Sawale S. Relation and Treatment Approach of Migraine in Pregnancy and Breastfeeding. Cureus. 2023;15(3):e36828. https://doi.org/10.7759/CUREUS.36828.
11. Tabeeva GR, Filatova EG, Amelin AV, Osipova VV, Artemenko AR, Akhmadeeva LR et al. Alternative and complementary treatments for migraine. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(1):4–15. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1-4-15.
12. Treadwell JR, Tsou AY, Rouse B, Ivlev I, Fricke J, Buse DC et al. Behavioral interventions for migraine prevention: A systematic review and metaanalysis. Headache. 2025;65(4):668–694. https://doi.org/10.1111/HEAD.14914.
13. Sturgeon JA, Ehde DM, Darnall BD, Barad MJ, Clauw DJ, Jensen MP. Psychological Approaches for Migraine Management. Anesthesiol Clin. 2023;41(2):341–355. https://doi.org/10.1016/J.ANCLIN.2023.02.002.
14. Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501–514. https://doi.org/10.1038/s41582-021-00509-5.
15. Mínguez-Olaondo A, Días PA, de Munáin EL, Grozeva V, Laspra-Solís C, Villalba IM et al. Behavioral therapy in migraine: Expanding the therapeutic arsenal. Eur J Neurol. 2024;31(12):e16414. https://doi.org/10.1111/ENE.16414.
16. Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21(1):126. https://doi.org/10.1186/S10194-020-01192-5.
17. Agbetou M, Adoukonou T. Lifestyle Modifications for Migraine Management. Front Neurol. 2022;13:719467. https://doi.org/10.3389/FNEUR.2022.719467.
18. La Touche R, Fernández Pérez JJ, Proy Acosta A, González Campodónico L, Martínez García S, Adraos Juárez D et al. Is aerobic exercise helpful in patients with migraine? A systematic review and meta-analysis. Scand J Med Sci Sports. 2020;30(6):965–982. https://doi.org/10.1111/SMS.13625.
19. Roldán-Ruiz A, Bertotti G, López-Moreno M. Effects of Dietary Interventions in Patients With Migraine: A Systematic Review. Nutr Rev. 2025;83(7):e1815–1827. https://doi.org/10.1093/NUTRIT/NUAE188.
20. Reina-Varona Á, Madroñero-Miguel B, Fierro-Marrero J, Paris-Alemany A, La Touche R. Efficacy of various exercise interventions for migraine treatment: A systematic review and network meta-analysis. Headache. 2024;64(7):873–900. https://doi.org/10.1111/HEAD.14696.
21. Anheyer D, Klose P, Lauche R, Saha FJ, Cramer H. Yoga for Treating Headaches: a Systematic Review and Meta-analysis. J Gen Intern Med. 2020;35(3):846–854. https://doi.org/10.1007/S11606-019-05413-9.
22. Tabeeva GR, Artemenko AR, Koreshkina MI, Osipova VV, Sergeev AV, Latysheva NV et al. Overcoming obstacles to effective treatment of patients with migraine (Statement of the expert group on optimizing treatment of patients with migraine). Neurology, Neuropsychiatry, Psychosomatics. 2025;17(2):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2025-2-4-14.
23. Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina. 2021;58(1):44. https://doi.org/10.3390/MEDICINA58010044.
24. Golovacheva VA. Personalized combination treatment including cognitive behavioural therapy in chronic migraine and depression: A prospective randomized trial. Meditsinskiy Sovet. 2025;19(13):95–99. (In Russ.) https://doi.org/10.21518/ms2025-319.
25. Giovanardi CM, Cinquini M, Aguggia M, Allais G, Campesato M, Cevoli S et al. Acupuncture vs. Pharmacological Prophylaxis of Migraine: A Systematic Review of Randomized Controlled Trials. Front Neurol. 2020;11:576272. https://doi.org/10.3389/FNEUR.2020.576272.
26. Hindiyeh NA, Zhang N, Farrar M, Banerjee P, Lombard L, Aurora SK. The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review. Headache. 2020;60(7):1300–1316. https://doi.org/10.1111/HEAD.13836.
27. Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S. Effects of selected dietary supplements on migraine prophylaxis: A systematic review and doseresponse meta-analysis of randomized controlled trials. Neurol Sci. 2025;46(2):651–670. https://doi.org/10.1007/S10072-024-07794-0.
28. Sazali S, Badrin S, Norhayati MN, Idris NS. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine – a meta-analysis. BMJ Open. 2021;11(1):e039358. https://doi.org/10.1136/BMJOPEN-2020-039358.
29. Hu C, Fan Y, Wu S, Zou Y, Qu X. Vitamin D supplementation for the treatment of migraine: A meta-analysis of randomized controlled studies. Am J Emerg Med. 2021;50:784–788. https://doi.org/10.1016/j.ajem.2021.07.062.
30. Chen YS, Lee HF, Tsai CH, Hsu YY, Fang CJ, Chen CJ et al. Effect of Vitamin B2 supplementation on migraine prophylaxis: a systematic review and metaanalysis. Nutr Neurosci. 2022;25(9):1801–1812. https://doi.org/10.1080/1028415X.2021.1904542.
31. Puliappadamb HM, Maiti R, Mishra A, Jena M, Mishra BR. Efficacy and Safety of Melatonin as Prophylaxis for Migraine in Adults: A Meta-analysis. J Oral Facial Pain Headache. 2022;36(3-4):3211. https://doi.org/10.11607/OFPH.3211.
32. Zhong J, Lan W, Feng Y, Yu L, Xiao R, Shen Y et al. Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: A meta-analysis. Front Neurol. 2022;13:1050090. https://doi.org/10.3389/FNEUR.2022.1050090.
33. Cheng YC, Zeng BY, Hung CM, Su KP, Wu YC, Tu YK et al. Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials. J Headache Pain. 2022;23(1):28. https://doi.org/10.1186/S10194-022-01401-3.
34. Haghdoost F, Salam A, Seyed-Kolbadi FZ, Padala D, Delcourt C, Rodgers A. Transcranial Direct Current Stimulation in Episodic Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Med Sci. 2025;13(3):84. https://doi.org/10.3390/MEDSCI13030084.
35. Moisset X, Pereira B, Ciampi de Andrade D, Fontaine D, Lantéri-Minet M, Mawet J. Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2020;21(1):142. https://doi.org/10.1186/S10194-020-01204-4.
36. Kuruvilla D, Mann JI, Schoenen J, Penning S. Acute treatment of migraine with external trigeminal nerve stimulation: A pilot trial. Cephalalgia Rep. 2019;2. https://doi.org/10.1177/2515816319829906.
37. Lai YH, Huang YC, Huang LT, Chen RM, Chen C. Cervical Noninvasive Vagus Nerve Stimulation for Migraine and Cluster Headache: A Systematic Review and Meta-Analysis. Neuromodulation. 2020;23(6):721–731. https://doi.org/10.1111/NER.13122.
38. Alnajjar AZ, Mustafa MMM, Abdelsalam OK, Sharabati I, Hassan AK, Allam M, Abouelmagd ME. Efficacy and safety of remote electrical neuromodulation in migraine: a comprehensive systematic review and meta-analysis. BMC Neurol. 2025;25(1):327. https://doi.org/10.1186/S12883-025-04291-5.
39. Ramaswamy S, Wodehouse T. Conditioned pain modulation – A comprehensive review. Neurophysiol Clin. 2021;51(3):197–208. https://doi.org/10.1016/J.NEUCLI.2020.11.002.
40. Lloyd J, Biloshytska M, Andreou A, Lambru G. Noninvasive Neuromodulation in Headache: An Update. Neurol India. 2021;69(Suppl. 1):S183–S193. https://doi.org/10.4103/0028-3886.315998.
41. Clark O, Mahjoub A, Osman N, Surmava AM, Jan S, Lagman-Bartolome AM. Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials. Neurol Sci. 2022;43(1):153–165. https://doi.org/10.1007/S10072-021-05664-7.
42. Vélez-Jiménez MK, Martínez-Mayorga AP, Rodriguez-Leyva I, FigueroaMedina MJ, Reyes-Alvarez MT, Pérez-García JC et al. Comprehensive preventive treatments for episodic migraine: a systematic review of randomized clinical trials. Front Neurol. 2025;16:1611303. https://doi.org/10.3389/FNEUR.2025.1611303.
43. Evans AG, Horrar AN, Ibrahim MM, Burns BL, Kalmar CL, Assi PE et al. Outcomes of transcutaneous nerve stimulation for migraine headaches: a systematic review and meta-analysis. J Neurol. 2022;269:4021–4029. https://doi.org/10.1007/S00415-022-11059-1.
Review
For citations:
Murtazina RT, Bordovsky SP, Varfolomeeva AV, Shevtsova KV. Non-pharmacological approaches to migraine management. Meditsinskiy sovet = Medical Council. 2025;(22):47-54. (In Russ.) https://doi.org/10.21518/ms2025-530


































